Premium
P4‐335: Donepezil in subcortical vascular cognitive impairment: A randomised double‐blind trial in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (cadasil)
Author(s) -
Dichgans Martin,
Markus Hugh S.,
Salloway Stephen,
Moline Margaret,
Wang Qin,
Posner Holly,
Chabriat Hugues S.
Publication year - 2008
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2008.05.2405
Subject(s) - donepezil , cadasil , placebo , vascular dementia , clinical endpoint , medicine , leukoencephalopathy , dementia , psychology , neuropsychology , cardiology , randomized controlled trial , cognition , psychiatry , pathology , disease , alternative medicine
Martin Dichgans, Hugh S. Markus, Stephen Salloway, Margaret Moline, Qin Wang, Holly Posner, Hugues S. Chabriat, Ludwig-Maximilians-University, Munich, Germany; Centre for Clinical Neuroscience, St. George‘s, University of London, London, United Kingdom; Memory and Aging Program, Butler Hospital, Providence, RI, USA; CNS I, Eisai Medical Research Inc, Ridgefield Park, NJ, USA; Clinical R&D, Pfizer Inc, New York, NY, USA; Department of Neurology, Hopital Lariboisière, University Paris 7 and INSERM U740, Paris, France. Contact e-mail: stephen_salloway@brown.edu